COVID ICU survivors: does lying on your belly help years later?
NCT ID NCT06080737
First seen Jun 26, 2026 · Last updated Jun 27, 2026 · Updated 1 time
Summary
This study checks on 137 COVID-19 patients who were in the ICU and used awake prone positioning (lying on their belly) while on high-flow oxygen. Researchers want to see if this technique affects quality of life and survival more than two years later. Participants answer a phone questionnaire about their health, mobility, and daily activities.
What this could mean
Our plain-language read of the trial. This is informational only, not medical advice or a prediction.
- What this could lead to
- If successful, this could show whether a simple positioning technique during ICU care improves long-term recovery and quality of life after severe COVID-19.
- What could go wrong
- This is an observational follow-up, not a new treatment test. Results may not apply to all patients, and quality-of-life measures can be subjective.
This is an AI summary of the original study and may miss details. Read our disclaimer.
Study facts
What this study's own registry entry says, in plain language.
- Participants
-
137 people
The number who actually took part.
- Started
-
May 2024
- Finished
-
Nov 2024
- Lead sponsor
-
Other sponsor
The registry's catch-all category, for sponsors it does not file as a company, a government agency, or a research network.
Who can take part
This study's own entry requirements. Only the study team can say for certain whether you qualify.
Who is studied
Patients included in France in the randomized study "High Prone Covid" alive at day 28 (NCT04358939).
- Ages
-
18 years and older
- Sex
-
Anyone
- Healthy volunteers
-
Not accepted
This study is not open to healthy volunteers. The entry requirements below say who it is open to.
Show the full entry requirements Hide the full entry requirements
Copied word for word from the study's registry entry, so the wording is the study team's rather than ours.
Inclusion Criteria: * Patients included in the randomized meta-trial evaluating awake prone position versus control among COVID-19 patients on high-flow nasal oxygen therapy (Ehrmann 2021). * Patients alive at D28 * No opposition to participate in the research which evaluates mortality and quality of life by telephone interview. Exclusion Criteria: * Patients lost to follow-up after 28 days. * Withdrawal of consent from randomized meta-trial by patient * Vulnerable person: safeguard of justice, curatorship, or guardianship * Patients refusing to answer telephone questionnaire.
Get updates
Get notified about this study
Sign up to get updates when this study changes or when new studies for SARS-CoV 2 pneumonia are added.
Genom att skicka in godkänner du våra Användarvillkor
Conditions
The condition(s) this trial relates to.
As listed by the trial registrant
The condition terms exactly as the trial's registrant entered them.
Contacts and locations
Locations
-
university hospital Tours
Tours, 37000, France
More trials for these conditions
Other studies related to the condition(s) this trial covers.